115 related articles for article (PubMed ID: 14661052)
1. Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells.
Wichert A; Stege A; Midorikawa Y; Holm PS; Lage H
Oncogene; 2004 Jan; 23(4):945-55. PubMed ID: 14661052
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Stein U; Scheffer GL; Lage H
Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
[TBL] [Abstract][Full Text] [Related]
3. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.
Dietel M; Arps H; Lage H; Niendorf A
Cancer Res; 1990 Sep; 50(18):6100-6. PubMed ID: 1975514
[TBL] [Abstract][Full Text] [Related]
4. Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo.
Umezu T; Shibata K; Shimaoka M; Kajiyama H; Yamamoto E; Ino K; Nawa A; Senga T; Kikkawa F
Cancer Sci; 2010 Jan; 101(1):143-8. PubMed ID: 19860840
[TBL] [Abstract][Full Text] [Related]
5. Selection of a high activity ribozyme against cytostatic drug resistance-associated glypican-3 using an in vitro assay containing total tumor RNA.
Wichert A; Holm PS; Dietel M; Lage H
Cancer Gene Ther; 1999; 6(3):263-70. PubMed ID: 10359212
[TBL] [Abstract][Full Text] [Related]
6. Identification of glypican-3 as a novel tumor marker for melanoma.
Nakatsura T; Kageshita T; Ito S; Wakamatsu K; Monji M; Ikuta Y; Senju S; Ono T; Nishimura Y
Clin Cancer Res; 2004 Oct; 10(19):6612-21. PubMed ID: 15475451
[TBL] [Abstract][Full Text] [Related]
7. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis of different multidrug-resistant gastric carcinoma cells.
Heim S; Lage H
In Vivo; 2005; 19(3):583-90. PubMed ID: 15875780
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
Peters MG; Farías E; Colombo L; Filmus J; Puricelli L; Bal de Kier Joffé E
Breast Cancer Res Treat; 2003 Jul; 80(2):221-32. PubMed ID: 12908826
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
[TBL] [Abstract][Full Text] [Related]
11. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
13. Structure, regulation and function of avian glypican.
Niu S; Bahl JJ; Adamson C; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):537-50. PubMed ID: 9515030
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
Grisaru S; Cano-Gauci D; Tee J; Filmus J; Rosenblum ND
Dev Biol; 2001 Mar; 231(1):31-46. PubMed ID: 11180950
[TBL] [Abstract][Full Text] [Related]
15. Selection and characterization of heat-resistant variants of multidrug-resistant human gastric carcinoma cell lines.
Jordan A; Scholz R
Exp Oncol; 2005 Mar; 27(1):18-23. PubMed ID: 15812352
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone.
Lage H; Perlitz C; Abele R; Tampé R; Dietel M; Schadendorf D; Sinha P
FEBS Lett; 2001 Aug; 503(2-3):179-84. PubMed ID: 11513878
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
Komori H; Nakatsura T; Senju S; Yoshitake Y; Motomura Y; Ikuta Y; Fukuma D; Yokomine K; Harao M; Beppu T; Matsui M; Torigoe T; Sato N; Baba H; Nishimura Y
Clin Cancer Res; 2006 May; 12(9):2689-97. PubMed ID: 16675560
[TBL] [Abstract][Full Text] [Related]
19. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
[TBL] [Abstract][Full Text] [Related]
20. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
Paine-Saunders S; Viviano BL; Saunders S
Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
